SECsense Logo

Summit Therapeutics Inc. 8-K Report: Key Updates & Stock Info for Investors

$SMMT
Form 8-K
Filed on: 2025-01-13
Source
Summit Therapeutics Inc. 8-K Report: Key Updates & Stock Info for Investors

Based on the provided XML snippet from the financial report, here are the key insights and information extracted:

  1. Entity Information:
  • Company Name: Summit Therapeutics Inc.
  • CIK: 0001599298
  • SEC File Number: 001-36866
  • Federal Tax ID: 37-1979717
  1. Address:
  • Location: 601 Brickell Key Drive, Suite 1000, Miami, FL 33131
  • Phone Number: (305) 203-2034
  1. Filing Type:
  • Form Type: 8-K (a current report that companies must file with the SEC to report major events that shareholders should know about)
  1. Filing Date:
  • Date of Filing: January 13, 2025
  1. Stock Information:
  • Type of Stock: Common stock
  • Par Value: $0.01 per share
  • Trading Symbol: SMMT
  • Exchange: NASDAQ
  1. Context Information:
  • The report covers a specific period starting and ending on January 13, 2025.
  1. Address Type:
  • The report indicates the entity’s former address, suggesting a change in location or a need to clarify previous address information.

Summary:

This financial report segment reveals that Summit Therapeutics Inc. filed an 8-K on January 13, 2025, detailing significant corporate information, including a change of address and their common stock details. The company is publicly traded on NASDAQ under the symbol SMMT. This report is essential for investors and stakeholders monitoring corporate governance and operational changes within the company.